Strain of bifidobacterium animalis ssp. animalis
A technology of animal Bifidobacterium and Bifidobacterium breve, applied in the direction of Bifidobacteria, microorganisms, microorganisms, etc., can solve the problems of increased mRNA expression, increased small intestine and colon myoelectric activity, VIP concentration has no significant effect, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] Example 1: Effect of lactic acid bacteria on neuronal VIP production in a co-culture model of ENS primary cultures and T84 cells
[0032] investigated the differential response of primary enteric neurons to VIP production after interacting with 107 probiotic strains, including lactic acid bacteria, especially bifidobacteria.
[0033] Bacterial Strains and Growth Conditions
[0034] Lactobacilli were grown in Man, Rogosa and Sharpe (MRS) medium (Biokar Diagnostics, Beauvais, France) at 37°C for 24 hours under aerobic conditions.
[0035] Bifidobacteria were cultured in a defined medium consisting of tryptone (Becton Dickinson, France) supplemented with glucose (Sigma, France), yeast extract (Becton Dickinson, USA) and hemin (Calbiochem, France). USA) and grown under anaerobic conditions at 37°C for 24 hours. Bifidobacterium animalis subsp. lactobacillus was cultured in MRS medium (Biokar Diagnostics) supplemented with cysteine (Sigma, France) and grown under anaerobi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com